The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
Akums invested Rs. 272 crore in capital expenditure during FY25
The CDMO upgrade represents a transformational step for Remedium Lifecare
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Subscribe To Our Newsletter & Stay Updated
